Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) had its price target reduced by equities researchers at Morgan Stanley from $56.00 to $50.00 in a report issued on Friday, Benzinga reports. The brokerage currently has an “underweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s price objective suggests a potential downside of 5.63% from the stock’s […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) had its price objective lowered by stock analysts at Morgan Stanley from $56.00 to $50.00 in a report issued on Friday, Benzinga reports. The firm currently has an “underweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price would suggest a potential downside of 5.63% from the […]
First Horizon Advisors Inc. lessened its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.6% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 97,741 shares of the biopharmaceutical company’s stock after selling 548 shares during the quarter. First Horizon Advisors Inc.’s […]
Steel Peak Wealth Management LLC grew its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,900 shares of the biopharmaceutical company’s stock after acquiring an additional 1,525 shares during the quarter. Steel Peak Wealth […]
Steel Peak Wealth Management LLC boosted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 12.3% during the second quarter, HoldingsChannel.com reports. The fund owned 13,900 shares of the biopharmaceutical company’s stock after buying an additional 1,525 shares during the quarter. Steel Peak Wealth Management LLC’s holdings in Bristol-Myers Squibb were worth $889,000 at […]